Please ensure Javascript is enabled for purposes of website accessibility

What's Behind Stryker's Solid Q3 Results

By Keith Speights - Updated Oct 30, 2019 at 9:20AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Here's how the medical-device giant met Wall Street Q3 revenue estimates and narrowly beat earnings expectations.

Stryker (SYK 1.98%) ranks as one of the biggest winners among blue-chip stocks so far in 2019. The medical device giant's shares have soared nearly 35% year to date.

That strong performance was put to the test when Stryker announced its third-quarter results after the market closed on Tuesday. However, Stryker didn't strike out. Here are the highlights from the company's Q3 update.

Physician showing a patient a human spine model

Image source: Getty Images.

By the numbers

Stryker reported revenue of $3.58 billion in the third quarter, up 10.6% year over year. This result matched the consensus Wall Street Q3 revenue estimate.

The company announced net income in the third quarter of $466 million, or $1.23 per share, based on generally accepted accounting principles (GAAP). This reflected significant deterioration from the GAAP net income of $590 million, or $1.55 per share, posted in the prior-year period.

Stryker reported adjusted net income of $1.91 per share, compared with $1.69 per share in the same period in 2018. This narrowly beat the average analysts' Q3 earnings estimate of $1.90 per share.

Behind the numbers

Sales in all of Stryker's business segments rose in the third quarter. Orthopedic sales increased by nearly 8% to $1.3 billion. Medical-surgical sales rose 9% to $1.6 billion. Neurotechnology and spine segment sales jumped 19% to $700 million. 

Foreign exchange fluctuations weighed on Stryker's Q3 revenue to some extent. On a constant-currency basis, the company's revenue increased by 11.5% over the prior-year period.

The company's bottom line, however, went in the wrong direction -- at least on a GAAP basis. What happened? Stryker's tax bill was a lot worse than a year ago. In the third quarter of 2018, the company enjoyed a $56 million tax benefit. Stryker paid $115 million in income taxes in the recent quarter. That swing caused the steep year-over-year decline in earnings.

Stryker's adjusted earnings per share (EPS) figure for Q3 factored out the impact of these taxes. On a more apples-to-apples basis, the company's bottom line improved nicely over the same quarter last year.

Looking ahead

CEO Kevin Lobo liked what he saw with Stryker's growth in Q3. He said the company expects "this momentum to continue, which positions us well to deliver above the high end of our initial guidance range for both organic sales and adjusted EPS."

Stryker's revised guidance backs up Lobo's optimism. The company now anticipates full-year adjusted net earnings per share to be between $8.20 and $8.25, compared with its prior guidance of $8.15 to $8.25. For the fourth quarter of 2019, Stryker expects adjusted net earnings per share to fall between $2.43 and $2.48.

Investors can also look forward to an impact from Stryker's acquisition of Mobius Imaging and its sister company, GYS Tech. Stryker announced the closing of this transaction on Oct. 21.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Stryker Corporation Stock Quote
Stryker Corporation
$219.20 (1.98%) $4.25

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/11/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.